IRB Number:

06-006141

Trial Status:

Open for Enrollment

Phase: I

Why is this study being done?

Develop an imaging technique to measure brain lithium levels. This could potentially improve the ability to predict lithium responses based on brain lithium levels rather than serum lithium levels.

While lithium is an effective medication for some bipolar patients, it doesn't work in others. We're trying to develop a new MRI scan to measure brain lithium levels in order to predict who will respond best to lithium therapy.

Who is Eligible to Participate in the Study?

Bipolar patients with normal mood states on stable lithium therapy for ≥ 3 months

Minimum Age:

18

Maximum Age:

65

What is Involved With this Study?

A single MRI scan lasting approximately 1.5 hours. Renumeration will be offered for completion of the study. Your participation will contribute to future improvements in clinically relevant imaging techniquest for bipolar patients

How long will the Study run?

1 scan

Who can I Contact for Additional Information on this Trial?

John Port, M.D., Ph.D., 507-293-3793, port.john@mayo.edu

What is/are the Locations of this Clinical Trial?

• Rochester, MN

Last updated: 03/19/2008